Sumitomo Pharma announces authorization in Canada of Orgovyx for treatment prostate cancer
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
UroKul, Pune is the largest centre to conduct reconstructive urology surgery outside USA and UK
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
Subscribe To Our Newsletter & Stay Updated